Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 6
1962 3
1963 7
1964 3
1965 5
1966 10
1967 3
1968 12
1969 5
1970 6
1971 3
1972 4
1973 5
1974 6
1975 6
1976 2
1977 2
1978 8
1979 5
1980 8
1981 10
1982 15
1983 10
1984 10
1985 15
1986 17
1987 16
1988 13
1989 16
1990 10
1991 15
1992 16
1993 9
1994 12
1995 11
1996 12
1997 9
1998 24
1999 20
2000 17
2001 17
2002 21
2003 18
2004 25
2005 18
2006 20
2007 19
2008 19
2009 14
2010 19
2011 23
2012 27
2013 25
2014 21
2015 32
2016 21
2017 46
2018 45
2019 43
2020 50
2021 53
2022 53
2023 46
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

1,006 results

Results by year

Filters applied: . Clear all
Page 1
Eosinophilic chronic rhinosinusitis.
Fujieda S, Imoto Y, Kato Y, Ninomiya T, Tokunaga T, Tsutsumiuchi T, Yoshida K, Kidoguchi M, Takabayashi T. Fujieda S, et al. Among authors: tokunaga t. Allergol Int. 2019 Oct;68(4):403-412. doi: 10.1016/j.alit.2019.07.002. Epub 2019 Aug 9. Allergol Int. 2019. PMID: 31402319 Free article. Review.
Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study.
Tokunaga T, Sakashita M, Haruna T, Asaka D, Takeno S, Ikeda H, Nakayama T, Seki N, Ito S, Murata J, Sakuma Y, Yoshida N, Terada T, Morikura I, Sakaida H, Kondo K, Teraguchi K, Okano M, Otori N, Yoshikawa M, Hirakawa K, Haruna S, Himi T, Ikeda K, Ishitoya J, Iino Y, Kawata R, Kawauchi H, Kobayashi M, Yamasoba T, Miwa T, Urashima M, Tamari M, Noguchi E, Ninomiya T, Imoto Y, Morikawa T, Tomita K, Takabayashi T, Fujieda S. Tokunaga T, et al. Allergy. 2015 Aug;70(8):995-1003. doi: 10.1111/all.12644. Epub 2015 May 26. Allergy. 2015. PMID: 25945591 Free PMC article.
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T. Shimada K, et al. Among authors: tokunaga t. Lancet Oncol. 2020 Apr;21(4):593-602. doi: 10.1016/S1470-2045(20)30059-0. Epub 2020 Mar 11. Lancet Oncol. 2020. PMID: 32171071 Clinical Trial.
[Eosinophilic chronic rhinosinusitis].
Fujieda S, Sakashita M, Tokunaga T, Okano M, Haruna T, Yoshikawa M, Ohtori N, Asaka D, Haruna S, Nakayama T, Ishitoya J, Sakuma Y, Hirakawa K, Takeno S, Himi T, Seki N, Iino Y, Yoshida N, Kobayashi M, Sakaida H, Kondo K, Yamasoba T, Miwa T, Yamada K, Kawata R, Terada T, Kawauchi H, Morikura I, Ikeda K, Murata J, Ikeda H, Noguchi E, Tamari M, Hirota T, Imoto Y, Takabayashi T, Tomita K, Ninomiya T, Morikawa T, Urashima M. Fujieda S, et al. Among authors: tokunaga t. Arerugi. 2015 Feb;64(1):38-45. Arerugi. 2015. PMID: 25779061 Review. Japanese. No abstract available.
Candidatus Mycoplasma haemohominis in Human, Japan.
Hattori N, Kuroda M, Katano H, Takuma T, Ito T, Arai N, Yanai R, Sekizuka T, Ishii S, Miura Y, Tokunaga T, Watanabe H, Nomura N, Eguchi J, Hasegawa H, Nakamaki T, Wakita T, Niki Y. Hattori N, et al. Among authors: tokunaga t. Emerg Infect Dis. 2020 Jan;26(1):11-19. doi: 10.3201/eid2601.190983. Emerg Infect Dis. 2020. PMID: 31855136 Free PMC article.
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Niizeki T, Tokunaga T, Takami Y, Wada Y, Harada M, Shibata M, Nakao K, Sasaki R, Hirai F, Shakado S, Yoshizumi T, Itoh S, Yatsuhashi H, Bekki S, Ido A, Mawatari S, Honda K, Sugimoto R, Senju T, Takahashi H, Kuwashiro T, Maeshiro T, Nakamuta M, Aratake Y, Yamashita T, Otsuka Y, Matsumoto S, Sohda T, Shimose S, Murotani K, Tanaka Y. Niizeki T, et al. Among authors: tokunaga t. Target Oncol. 2022 Nov;17(6):643-653. doi: 10.1007/s11523-022-00921-x. Epub 2022 Oct 22. Target Oncol. 2022. PMID: 36272060 Free PMC article.
Acute in-competition medical care at the Tokyo 2020 Olympics: a retrospective analysis.
Tanaka H, Tanaka S, Yokota H, Otomo Y, Masuno T, Nakano K, Sugita M, Tokunaga T, Sugimoto K, Inoue J, Kato N, Kinoshi T, Sakanashi S, Inoue H, Numata H, Nakagawa K, Miyamoto T, Akama T. Tanaka H, et al. Among authors: tokunaga t. Br J Sports Med. 2023 Nov;57(21):1361-1370. doi: 10.1136/bjsports-2022-105778. Epub 2023 Apr 13. Br J Sports Med. 2023. PMID: 37055080
1,006 results